HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism.

AbstractAIMS:
Hypolipidemic drugs are prescribed in the most of cases for the treatment of cardiovascular diseases. Several studies have showed that the gut microbiota is able to regulate the host cholesterol metabolism. This study aimed to investigate the potential impact of hypolipidemic drugs on the gut microbiota in mice, and to correlate it to the regulation of cholesterol metabolism.
MAIN METHODS:
Male C57Bl/6J mice were divided into four groups fed either a control diet alone (CT), or supplemented with simvastatin (0.1% w/w, Zocor®, MSD), or ezetimibe (0.021% w/w, Ezetrol®, MSD) or a combination of simvastatin and ezetimibe (0.1% and 0.021%, respectively) for one week.
KEY FINDINGS:
The combination of ezetimibe and simvastatin is required to observe a drop in cholesterolemia, linked to a huge activation of hepatic SREBP-2 and the consequent increased expression of genes involved in LDL cholesterol uptake and cholesterol synthesis. The gut microbiota analysis revealed no change in total bacteria, and in major Gram positive and Gram negative bacteria, but a selective significant increase in Lactobacillus spp. in mice treated with the ezetimibe and a decrease by the combination. The changes in lactobacilli level observed in ezetimibe or combination treated-mice are negatively correlated to expression of genes related to cholesterol metabolism.
SIGNIFICANCE:
The present study showed that ezetimibe taken alone is able to modify the composition of gut microbiota in favor of Lactobacillus spp. These results suggest that members of the genus Lactobacillus play an important role in cholesterol metabolism, even in normocholesterolemic mouse model.
AuthorsEmilie Catry, Barbara D Pachikian, Nuria Salazar, Audrey M Neyrinck, Patrice D Cani, Nathalie M Delzenne
JournalLife sciences (Life Sci) Vol. 132 Pg. 77-84 (Jul 01 2015) ISSN: 1879-0631 [Electronic] Netherlands
PMID25916803 (Publication Type: Journal Article)
CopyrightCopyright © 2015. Published by Elsevier Inc.
Chemical References
  • Azetidines
  • DNA Primers
  • Srebf2 protein, mouse
  • Sterol Regulatory Element Binding Protein 2
  • Cholesterol
  • Simvastatin
  • Ezetimibe
Topics
  • Analysis of Variance
  • Animals
  • Azetidines (pharmacology)
  • Blotting, Western
  • Cholesterol (biosynthesis, metabolism)
  • DNA Primers (genetics)
  • Drug Evaluation, Preclinical
  • Drug Therapy, Combination
  • Ezetimibe
  • Gastrointestinal Tract (microbiology)
  • Gene Expression Regulation (drug effects, genetics)
  • Lactobacillus (drug effects, growth & development)
  • Liver (metabolism)
  • Male
  • Metabolic Networks and Pathways (genetics)
  • Mice
  • Mice, Inbred C57BL
  • Microbiota (drug effects)
  • Real-Time Polymerase Chain Reaction
  • Simvastatin (pharmacology)
  • Sterol Regulatory Element Binding Protein 2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: